|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 42.39 EUR | -1.22% |
|
+1.55% | +14.33% |
| 20/01 | DAX Index Extends Losing Streak; German Economic Sentiment Improves | MT |
| 20/01 | Illumina Secures Reimbursement of Nearly $3,000 Per TruSight Test | MT |
Company Valuation: Bayer AG
Data adjusted to current consolidation scope
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 47,309 | 46,174 | 47,476 | 33,039 | 18,975 | 42,161 | 42,161 | - |
| Change | - | -2.4% | 2.82% | -30.41% | -42.57% | 122.2% | 0% | - |
| Enterprise Value (EV) 1 | 84,884 | 79,140 | 78,749 | 67,302 | 51,329 | 73,900 | 70,930 | 68,380 |
| Change | - | -6.77% | -0.49% | -14.54% | -23.73% | 43.98% | -4.02% | -3.59% |
| P/E ratio | -4.51x | 46.1x | 11.5x | -11.2x | -7.43x | 183x | 16.8x | 13.9x |
| PBR | 1.55x | 1.4x | 1.22x | 1x | 0.59x | 1.29x | 1.2x | 1.12x |
| PEG | - | -0x | 0x | 0x | 0.6x | -2x | 0x | 0.7x |
| Capitalization / Revenue | 1.14x | 1.05x | 0.94x | 0.69x | 0.41x | 0.92x | 0.92x | 0.89x |
| EV / Revenue | 2.05x | 1.8x | 1.55x | 1.41x | 1.1x | 1.62x | 1.54x | 1.45x |
| EV / EBITDA | 7.41x | 7.08x | 5.83x | 5.75x | 5.07x | 7.74x | 7.35x | 6.7x |
| EV / EBIT | 12x | 10.8x | 8.51x | 8.87x | 9.44x | 13.8x | 12.3x | 11.1x |
| EV / FCF | 34.2x | 31.9x | 19x | 28.4x | 11.2x | 34.3x | 18.3x | 18.2x |
| FCF Yield | 2.93% | 3.13% | 5.26% | 3.52% | 8.94% | 2.92% | 5.48% | 5.51% |
| Dividend per Share 2 | 2 | 2 | 2.4 | 0.11 | 0.11 | 0.1121 | 0.5397 | 1.16 |
| Rate of return | 4.15% | 4.26% | 4.97% | 0.33% | 0.57% | 0.26% | 1.26% | 2.7% |
| EPS 2 | -10.68 | 1.02 | 4.22 | -2.99 | -2.6 | 0.2347 | 2.555 | 3.09 |
| Distribution rate | -18.7% | 196% | 56.9% | -3.68% | -4.23% | 47.8% | 21.1% | 37.5% |
| Net sales 1 | 41,400 | 44,081 | 50,739 | 47,637 | 46,606 | 45,700 | 45,986 | 47,160 |
| EBITDA 1 | 11,461 | 11,179 | 13,513 | 11,706 | 10,123 | 9,542 | 9,657 | 10,202 |
| EBIT 1 | 7,095 | 7,295 | 9,257 | 7,589 | 5,436 | 5,352 | 5,760 | 6,161 |
| Net income 1 | -10,495 | 1,000 | 4,150 | -2,941 | -2,552 | 590.5 | 2,597 | 3,144 |
| Net Debt 1 | 37,575 | 32,966 | 31,273 | 34,263 | 32,354 | 31,740 | 28,769 | 26,220 |
| Reference price 2 | 48.16 | 47.00 | 48.32 | 33.63 | 19.31 | 42.92 | 42.92 | 42.92 |
| Nbr of stocks (in thousands) | 9,82,424 | 9,82,424 | 9,82,424 | 9,82,424 | 9,82,424 | 9,82,424 | 9,82,424 | - |
| Announcement Date | 25/02/21 | 01/03/22 | 28/02/23 | 05/03/24 | 04/03/25 | - | - | - |
1EUR in Million2EUR
Estimates
P/E ratio, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 182.82x | 1.62x | 7.74x | 0.26% | 4.95TCr | ||
| 45.4x | 15.04x | 33.53x | 0.57% | 93TCr | ||
| 21.3x | 5.88x | 16.33x | 2.37% | 53TCr | ||
| 60.77x | 7.13x | 17.1x | 3.06% | 38TCr | ||
| 20.32x | 5.04x | 12.55x | 2.86% | 37TCr | ||
| 27.91x | 5.2x | 15.4x | 1.78% | 28TCr | ||
| 20.21x | 5.37x | 12.59x | 2.83% | 28TCr | ||
| 16.86x | 5.96x | 12.33x | 2.99% | 27TCr | ||
| 14.02x | 4.6x | 9.89x | 2.95% | 27TCr | ||
| 25.87x | 6.13x | 10.5x | 2.89% | 18TCr | ||
| Average | 43.55x | 6.20x | 14.80x | 2.26% | 35.41TCr | |
| Weighted average by Cap. | 33.79x | 8.10x | 18.96x | 2.1% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Equities
- BAYN Stock
- Valuation Bayer AG
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















